Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Uric acid (UA) is a purine metabolite that selectively inhibits peroxynitrite-mediated reactions implicated in the pathogenesis of multiple sclerosis (MS) and other neurodegenerative diseases. Serum UA levels are inversely associated with the incidence of MS in humans because MS patients have low serum UA levels and individuals with hyperuricemia (gout) rarely develop the disease. Moreover, the administration of UA is therapeutic in experimental allergic encephalomyelitis (EAE), an animal model of MS. Thus, raising serum UA levels in MS patients, by oral administration of a UA precursor such as inosine, may have therapeutic value. We have assessed the effects of inosine, as well as inosinic acid, on parameters relevant to the chemical reactivity of peroxynitrite and the pathogenesis of EAE. Both had no effect on chemical reactions associated with peroxynitrite, such as tyrosine nitration, or on the activation of inflammatory cells in vitro . Moreover, when mice treated with the urate oxidase inhibitor potassium oxonate were fed inosine or inosinic acid, serum UA levels were elevated markedly for a period of hours, whereas only a minor, transient increase in serum inosine was detected. Administration of inosinic acid suppressed the appearance of clinical signs of EAE and promoted recovery from ongoing disease. The therapeutic effect on animals with active EAE was associated with increased UA, but not inosine, levels in CNS tissue. We, therefore, conclude that the mode of action of inosine and inosinic acid in EAE is via their metabolism to UA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of inosine supplementation on aerobic and anaerobic cycling performance
STARLING, R. D., TRAPPE, T. A., SHORT, K. R., SHEFFIELD-MOORE, M., JOZSI, A. C., FINK, W. J., & COSTILL, D. L. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199609000-00017 · Cited by 53
Effect of inosine supplementation on 3-mile treadmill run performance and &OV0312;o2 peak
WILLIAMS, M. H., KREIDER, R. B., HUNTER, D. W., SOMMA, C. T., SHALL, L. M., WOODHOUSE, M. L., & ROKITSKI, L. (1990) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199008000-00017 · Cited by 38
Cited by
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Lotito, S. B., & Frei, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.033 · Cited by 770
RetractedThe physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 713
Plasma Urate and Risk of Parkinson's Disease
Weisskopf, M., O'Reilly, E., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm127 · Cited by 390
Metadata
- Authors
- Scott, G. S., Spitsin, S. V., Kean, R. B., Mikheeva, T., Koprowski, H., & Hooper, D. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-11-25
- Volume
- 99
- Issue
- 25
- Pages
- 16303-16308
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2036589433
- Cited by
- 128
- References
- 2
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. https://app.cochat.ai/papers/10.1073/pnas.212645999
- The paper
- Scott, G. S., Spitsin, S. V., Kean, R. B., Mikheeva, T., Koprowski, H., & Hooper, D. C. (2002). Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.212645999
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.